Usefulness of Immunostaining Scoring for Predicting Response to Single-Agent Nivolumab in Patients with Metastatic Renal Cell Carcinoma
Although several biomarkers have been identified to predict prognosis in renal cell carcinoma (RCC), there are no evidence-based biomarkers to predict the response to immune checkpoint inhibitors. In this study, we focused on lymphocytes and tumor cells in the tumor microenvironment and investigated...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 68(2022), 10 vom: 04. Okt., Seite 311-315
|
|---|
| 1. Verfasser: |
Wakamiya, Takahito
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Kubo, Terufumi,
Yamashita, Shimpei,
Kohjimoto, Yasuo,
Torigoe, Toshihiko,
Hara, Isao |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Japanese |
|---|
| Veröffentlicht: |
2022
|
|---|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Schlagworte: | English Abstract
Journal Article
Nivolumab
31YO63LBSN
B7-H1 Antigen
Antineoplastic Agents, Immunological |
|---|